Gilead Sciences to Present at Two Upcoming Investor Conferences
February 09 2012 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John
F. Milligan, PhD, Gilead’s President and Chief Operating Officer,
will be participating in “fireside chat” forums at two upcoming
investor conferences taking place in New York. The first will take
place at the BIO CEO & Investor Conference, available via a
replay on Gilead’s website after 4:00 p.m. Eastern Time (ET), on
Tuesday, February 14. The second will occur at the Leerink Swan
Global Healthcare Conference 2012 on Wednesday, February 15 at
11:00 a.m. ET, available via webcast.
To access the webcasts or a replay via the Internet, log on to
www.gilead.com. For the Leerink Swan presentation, please connect
to the company’s website at least 15 minutes prior to the start of
the presentation to ensure adequate time for any software download
that may be necessary to listen to the webcast. The replays will be
available for 14 days following the presentations.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please
visit www.gilead.com or call the Gilead Public Affairs Department
at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2024 to Jun 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2023 to Jun 2024